Differentiating primary and secondary FSGS using non-invasive urine biomarkers.

导出 OA

翻译打印收藏纠错

第一作者： Lorenzo,Catanese

第一单位： Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany.

作者： Lorenzo,Catanese ^[1] ; Justyna,Siwy ^[2] ; Ralph,Wendt ^[3] ; Kerstin,Amann ^[4] ; Joachim,Beige ^[5] ; Bruce,Hendry ^[6] ; Harald,Mischak ^[7] ; William,Mullen ^[8] ; Ian,Paterson ^[9] ; Mario,Schiffer ^[4] ; Michael,Wolf ^[10] ; Harald,Rupprecht ^[9]

作者单位： Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany. ^[1] Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, Bayreuth, Germany. ^[2] Medizincampus Oberfranken, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. ^[3] Mosaiques Diagnostics GmbH, Hannover, Germany. ^[4] Division of Nephrology, St. Georg Hospital Leipzig, Leipzig, Germany. ^[5] Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. ^[6] Kuratorium for Dialysis and Transplantation (KfH) Renal Unit, Leipzig, Germany. ^[7] Department of Internal Medicine II, Martin-Luther-University Halle/Wittenberg, Halle/Saale, Germany. ^[8] Travere Therapeutics, San Diego, CA, USA. ^[9] Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. ^[10] Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany. ^[11] Research Center on Rare Kidney Diseases (RECORD), University Hospital Erlangen, Erlangen, Germany. ^[12] Travere Therapeutics, Dublin, Ireland. ^[13]

关键词 FSGS biomarkers non-invasive peptides proteomics urine

DOI 10.1093/ckj/sfad296

PMID 38313685

发布时间 2024-02-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交